ISIN: XXXXXXXXXXXXX-XXXX Updated at 11:05:33
Status as of 18 March 2019
This graph represents Sequana Medical’s major shareholders, based on transparency notifications received by the Company, to date.
The Belgian Transparency Act refers to article 14 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings in issuers shares of which are admitted to trading on a regulated market and laying down miscellaneous provision.
Pursuant to this Belgian Transparency Act and the articles of association of the Company, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.
For more information and the appropriate transparency forms, please contact Sequana Medical Investor Relations (email@example.com) or the FSMA.
|Shareholder||Date of notification||Transparency notification||Press release|
|Newton Biocapital I Pricav Privée SA||21-Feb-2019||Download pdf||25-Feb-2019|
|Venture Incubator AG / VI Partners AG||21-Feb-2019||Download pdf||25-Feb-2019|
|NeoMed IV Extension L.P. / NeoMed Innovation V L.P.||20-Feb-2019||Download pdf||25-Feb-2019|
|LSP Health Economics Fund Management B.V.||19-Feb-2019||Download pdf||25-Feb-2019|
|Federale Participatie- en Investeringsmaatschappij N.V.||18-Feb-2019||Download pdf||25-Feb-2019|
|Participatiemaatschappij Vlaanderen NV||18-Feb-2019||Download pdf||25-Feb-2019|
|Capricorn Health-tech Fund NV / Quest for Growth NV||18-Feb-2019||Download pdf||25-Feb-2019|
Lenny Van Steenhuyse & Sandra Cauwenberghs
Alex Cogut & Ingrid Gafanhao
Any opinions, estimates or forecasts regarding Sequana Medical’s performance made by these analysts are those of the author and do not reflect the views of Sequana Medical and its management. Sequana Medical does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
To obtain a copy of their research reports, please contact their respective institutions.
MAY 23, 2019
APRIL 25, 2019
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.